Vertebral osteomyelitis and prosthetic joint infection due to Staphylococcus simulans

Mayo Clinic Proceedings
R R RazonableD R Osmon

Abstract

Staphylococcus simulans, a coagulase-negative staphylococcus, is a common animal pathogen that is rarely encountered in human infections. We describe a 70-year-old man who developed multifocal vertebral osteomyelitis and late prosthetic joint infection caused by this pathogen. The patient was a farmer who had daily contact with cows and drank unpasteurized milk, although the portal of the pathogen's entry remains speculative. Culture of the vertebral disk biopsy specimen and cultures during resection arthroplasty yielded S. simulans. A review of the literature suggests that S. simulans may be more virulent than other species of coagulase-negative staphylococci. Accurate identification of S. simulans isolates would facilitate studies to further define its pathogenic role in human infections.

Citations

Jul 5, 2007·Journal of Clinical Microbiology·Diane M CitronMurray A Abramson
Jun 1, 2011·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Jae-Ik HanKi-Jeong Na
Nov 15, 2011·Diabetes & Metabolism·C Désidéri-VaillantX Nicolas
Aug 7, 2009·Environmental Pollution·María Cambra-LópezAntonio G Torres
Aug 15, 2006·Clinical Orthopaedics and Related Research·Camelia E MarculescuDouglas R Osmon
Apr 4, 2014·Clinical Microbiology Reviews·Aaron J Tande, Robin Patel
Apr 28, 2020·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Kevin MullinsJeremiah W Ray
Nov 9, 2018·Case Reports in Infectious Diseases·Amos LalGeorge M Abraham
Aug 2, 2005·Clinical Orthopaedics and Related Research·Rodney M Donlan
Jul 2, 2021·IDCases·Ana DrobeniucNadine Rouphael

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.